Cargando…
Consideration with “Intratumoral gene therapy versus intravenous gene therapy for distant metastasis control with DDMC non-viral vector–p53”
Autores principales: | Onishi, Y., Zarogoulidis, P., Ji, R-C, Onishi, M., Kubota, N., Eshita, Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505222/ https://www.ncbi.nlm.nih.gov/pubmed/34635820 http://dx.doi.org/10.1038/s41434-021-00298-y |
Ejemplares similares
-
DDMC-p53 gene therapy with or without cisplatin and microwave ablation
por: Hohenforst-Schmidt, Wolfgang, et al.
Publicado: (2015) -
Mechanism of Introduction of Exogenous Genes into Cultured Cells Using DEAE-Dextran-MMA Graft Copolymer as Non-Viral Gene Carrier
por: Eshita, Yuki, et al.
Publicado: (2009) -
Viral Vectors in Gene Therapy
por: Lundstrom, Kenneth
Publicado: (2018) -
Viral Vector-Based Gene Therapy
por: Li, Xuedan, et al.
Publicado: (2023) -
Establishment of the Asia Oncology Nursing Society (AONS)
por: Onishi, Kazuko
Publicado: (2014)